Atorvastatin (Atorvastatin)



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 44.8%
Blood Cholesterol Increased 19.4%
Hypercholesterolaemia 9.0%
Acute Myocardial Infarction 4.5%
Cellulitis 3.0%
Low Density Lipoprotein Increased 3.0%
Myocardial Ischaemia 3.0%
Antiplatelet Therapy 1.5%
Blood Cholesterol 1.5%
Blood Cholesterol Decreased 1.5%
Coronary Artery Disease 1.5%
Dyslipidaemia 1.5%
Hypertension 1.5%
Niddm 1.5%
Osteomyelitis Chronic 1.5%
Prophylaxis 1.5%
Rhabdomyolysis 14.8%
Myalgia 7.4%
Product Substitution Issue 7.4%
Pruritus 7.4%
Weight Decreased 7.4%
Abdominal Pain Upper 3.7%
Alopecia 3.7%
Blood Pressure Increased 3.7%
Continuous Haemodiafiltration 3.7%
Drug Intolerance 3.7%
Dysstasia 3.7%
Exposure Via Partner 3.7%
General Physical Health Deterioration 3.7%
Hallucinations, Mixed 3.7%
Memory Impairment 3.7%
Musculoskeletal Discomfort 3.7%
Myocardial Infarction 3.7%
Myopathy 3.7%
Myositis 3.7%
Overdose 3.7%
Secondary
Product Used For Unknown Indication 42.0%
Hypercholesterolaemia 14.9%
Blood Cholesterol Increased 7.7%
Hypertension 7.7%
Anaesthesia 3.3%
Rheumatoid Arthritis 2.8%
Antiplatelet Therapy 2.2%
Cerebrovascular Accident Prophylaxis 2.2%
Drug Use For Unknown Indication 2.2%
Ischaemic Heart Disease Prophylaxis 2.2%
Pain 2.2%
Coronary Artery Disease 1.7%
Asthma 1.1%
Cardiovascular Event Prophylaxis 1.1%
Cholesterol High 1.1%
Chronic Obstructive Pulmonary Disease 1.1%
Duodenal Ulcer 1.1%
Dyslipidaemia 1.1%
Functional Gastrointestinal Disorder 1.1%
Low Density Lipoprotein Increased 1.1%
Colitis Microscopic 8.3%
Dyspnoea 8.3%
Toxicity To Various Agents 8.3%
Vomiting 8.3%
Liver Injury 5.6%
Polymyositis 5.6%
Pruritus 5.6%
Renal Disorder 5.6%
Rhabdomyolysis 5.6%
Upper Gastrointestinal Haemorrhage 5.6%
Weight Decreased 5.6%
Wound Infection Staphylococcal 5.6%
Blood Bilirubin Increased 2.8%
Blood Potassium Increased 2.8%
Completed Suicide 2.8%
Diabetes Mellitus 2.8%
Diarrhoea 2.8%
Drug Interaction 2.8%
Drug Reaction With Eosinophilia And Systemic Symptoms 2.8%
Epistaxis 2.8%
Concomitant
Product Used For Unknown Indication 42.1%
Hypertension 14.0%
Chronic Myeloid Leukaemia 4.9%
Depression 4.9%
Type 2 Diabetes Mellitus 4.9%
Plasma Cell Myeloma 2.8%
Prophylaxis 2.8%
Bipolar Disorder 2.5%
Actinic Keratosis 2.1%
Myocardial Ischaemia 2.1%
Urinary Tract Infection 2.1%
Acute Myocardial Infarction 1.8%
Coronary Artery Disease 1.8%
Drug Use For Unknown Indication 1.8%
Lung Neoplasm Malignant 1.8%
Multiple Sclerosis 1.8%
Thrombosis Prophylaxis 1.8%
Atrial Fibrillation 1.4%
Epilepsy 1.4%
Myelodysplastic Syndrome 1.4%
Ventricular Tachycardia 8.7%
Paraesthesia 7.6%
Vision Blurred 7.6%
Vomiting 6.5%
Weight Decreased 6.5%
Renal Failure Acute 5.4%
Tremor 5.4%
Urosepsis 5.4%
Pancreatitis 4.3%
Pulmonary Oedema 4.3%
Somnolence 4.3%
Treatment Failure 4.3%
Upper Gastrointestinal Haemorrhage 4.3%
Urticaria 4.3%
Weight Increased 4.3%
Drug Ineffective 3.3%
Headache 3.3%
Nausea 3.3%
Oedema Peripheral 3.3%
Osteonecrosis Of Jaw 3.3%